Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Transplantation|December 2, 2017
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective studyRaffaella Lionetti, Vincenza Calvaruso, Paola Piccolo, et al.Vaccines|September 28, 2024
Impact of Anti-SARS-CoV-2 Vaccination on Disease Severity and Clinical Outcomes of Individuals Hospitalized for COVID-19 Throughout Successive Pandemic Waves: Data from an Italian Reference HospitalAnnalisa Mondi, Ilaria Mastrorosa, Assunta Navarra, et al.International Journal of Antimicrobial Agents|January 18, 2025
Comparison of piperacillin-tazobactam and vancomycin (TZP-VAN) with piperacillin-tazobactam and teicoplanin (TZP-TEI) for the risk of acute kidney injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort studyAbdullah Tarık Aslan, Emre Kara, Gamze Köksal, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 19, 2016
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infectionRobert J Fontana, Robert S Brown, Ana Moreno-Zamora, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2021
Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospitalAnnalisa Mondi, Patrizia Lorenzini, Concetta Castilletti, et al.Pageof 2